Pharma company Viiv's attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India

.post-filter-container .filters .dropdown-selected::after{--wpr-bg-bac3dc96-3879-4280-92fd-2f0a8d0efeb1: url('https://msfsouthasia.org/wp-content/uploads/2026/01/Vector5.png');}.main-filter-shortcode .filter-section .single-filter{--wpr-bg-b0a0a8e6-a276-4e86-bbe8-ccefd39001b5: url('https://msfsouthasia.org/wp-content/uploads/2026/01/Vector5.png');}.addtoany_list .a2a_button_copy_link{--wpr-bg-6ae7cacd-adcd-4990-a486-1e5a40554c29: url('https://msfsouthasia.org/wp-content/themes/generatepress-child/');}.donation-bg-cont{--wpr-bg-5a1204f7-56aa-435a-a537-a436babdd028: url('https://msfsouthasia.org/wp-content/uploads/2026/02/Group-1410086062.png');}.rll-youtube-player .play{--wpr-bg-5f94e4f9-0d51-4d96-905b-cdc10e23cda6: url('https://msfsouthasia.org/wp-content/plugins/wp-rocket/assets/img/youtube.png');}

In Focus › Stories

February 10, 2016

Subscribe to newsletter

Impact Stories

Pharma company Viiv's attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India

Related News & stories

A Brush with Memory: Between Home and Displacement

Eastern Chad: One in five pregnant women malnourished amid critical funding cuts

Nigeria: “She used to ask me if her face could be corrected”